ARROWHEAD PHARMACEUT

ARWR
Delayed Quote. Delayed  - 01/22 04:00:00 pm
82.07USD +2.56%

Turn to zoom
Prev.80.0200
Open79.8100
High82.2400
Low79.5000
Volume559 007
Latest news
4d ago
4d ago
01/15
01/13
Chart ARROWHEAD PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance85,485,484,2
Spread/Res.-3,9%-3,9%-2,5%
Spread/Supp.13%44%78%
Support72,657,046,1
Financials
Sales 2021 198 M - -
Net income 2021 -8,44 M - -
Net cash 2021 286 M - -
P/E ratio 2021 -335x
Yield 2021 -
Capitalization 8 433 M 8 433 M -
EV / Sales 2021 41,1x
EV / Sales 2022 47,1x
Nbr of Employees 232
Free-Float 96,5%
Company
Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-02-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 82,46 $
Last Close Price 82,07 $
Spread / Highest target 21,8%
Spread / Average Target 0,48%
Spread / Lowest Target -58,6%